| Vitamin D modulation of innate immune responses to respiratory viral infections MT Zdrenghea, H Makrinioti, C Bagacean, A Bush, SL Johnston, ... Reviews in medical virology 27 (1), e1909, 2017 | 311 | 2017 |
| Accurate classification of germinal center B-cell–like/activated B-cell–like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase–multiplex ligation … S Mareschal, P Ruminy, C Bagacean, V Marchand, M Cornic, JP Jais, ... The Journal of Molecular Diagnostics 17 (3), 273-283, 2015 | 82 | 2015 |
| Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjögren's syndrome A Charras, OD Konsta, C Le Dantec, C Bagacean, EK Kapsogeorgou, ... Annals of the rheumatic diseases 76 (3), 625-628, 2017 | 54 | 2017 |
| Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies C Ilcus, C Bagacean, A Tempescul, C Popescu, A Parvu, M Cenariu, ... OncoTargets and therapy, 2349-2363, 2017 | 49 | 2017 |
| Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia C Bagacean, R Letestu, C Al-Nawakil, S Brichler, V Lévy, N Sritharan, ... Blood advances 6 (1), 207-211, 2022 | 46 | 2022 |
| Complement system: a neglected pathway in immunotherapy A Bordron, C Bagacean, A Tempescul, C Berthou, E Bettacchioli, S Hillion, ... Clinical reviews in allergy & immunology 58, 155-171, 2020 | 36 | 2020 |
| Simulated patient and role play methodologies for communication skills and empathy training of undergraduate medical students C Bagacean, I Cousin, AH Ubertini, M El Yacoubi El Idrissi, A Bordron, ... BMC medical education 20, 1-8, 2020 | 33 | 2020 |
| Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy A Bordron, C Bagacean, A Mohr, A Tempescul, B Bendaoud, S Deshayes, ... Oncotarget 9 (60), 31590, 2018 | 30 | 2018 |
| SERS assessment of the cancer-specific methylation pattern of genomic DNA: Towards the detection of acute myeloid leukemia in patients undergoing hematopoietic stem cell … V Moisoiu, A Stefancu, SD Iancu, T Moisoiu, L Loga, L Dican, CD Alecsa, ... Analytical and bioanalytical chemistry 411, 7907-7913, 2019 | 28 | 2019 |
| Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises C Bagacean, M Zdrenghea, A Tempescul, V Cristea, Y Renaudineau Immunotherapy 8 (5), 569-581, 2016 | 22 | 2016 |
| Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia A Mohr, Y Renaudineau, C Bagacean, JO Pers, C Jamin, A Bordron Oncoimmunology 5 (5), e1132977, 2016 | 19 | 2016 |
| Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion C Bagacean, C Le Dantec, C Berthou, A Tempescul, H Saad, A Bordron, ... Clinical Epigenetics 9, 1-11, 2017 | 18 | 2017 |
| Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion A Tempescul, C Bagacean, C Riou, B Bendaoud, S Hillion, M Debant, ... European Journal of Haematology 96 (3), 229-235, 2016 | 18 | 2016 |
| STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia M Debant, M Burgos, P Hemon, P Buscaglia, T Fali, S Melayah, ... Journal for immunotherapy of cancer 7, 1-13, 2019 | 17 | 2019 |
| 17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia C Bagacean, A Tempescul, D Ternant, A Banet, N Douet-Guilbert, ... Journal for ImmunoTherapy of Cancer 7, 1-5, 2019 | 15 | 2019 |
| Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia C Bagacean, A Tempescul, C Le Dantec, A Bordron, A Mohr, H Saad, ... Oncotarget 8 (39), 65699, 2017 | 14 | 2017 |
| MicroRNAs associated with a good prognosis of acute myeloid leukemia and their effect on macrophage polarization A Neaga, C Bagacean, A Tempescul, L Jimbu, O Mesaros, C Blag, ... Frontiers in immunology 11, 582915, 2021 | 13 | 2021 |
| Hyposialylation must be considered to develop future therapies in autoimmune diseases A Bordron, M Morel, C Bagacean, M Dueymes, P Pochard, ... International Journal of Molecular Sciences 22 (7), 3402, 2021 | 12 | 2021 |
| Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectives C Bagacean, C Tomuleasa, A Tempescul, R Grewal, WH Brooks, ... Critical reviews in clinical laboratory sciences 56 (5), 321-332, 2019 | 11 | 2019 |
| Rapid and complete response to idelalisib in a case of Richter syndrome C Bagacean, M Zdrenghea, H Saad, C Berthou, Y Renaudineau, ... OncoTargets and therapy, 1181-1184, 2019 | 9 | 2019 |
